SE8702907L - STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTIC COLONIST STIMULATING FACTOR AND A SET OF PRODUCING ITS - Google Patents

STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTIC COLONIST STIMULATING FACTOR AND A SET OF PRODUCING ITS

Info

Publication number
SE8702907L
SE8702907L SE8702907A SE8702907A SE8702907L SE 8702907 L SE8702907 L SE 8702907L SE 8702907 A SE8702907 A SE 8702907A SE 8702907 A SE8702907 A SE 8702907A SE 8702907 L SE8702907 L SE 8702907L
Authority
SE
Sweden
Prior art keywords
stimulating factor
pharmaceutical preparation
colonist
granulocytic
producing
Prior art date
Application number
SE8702907A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE503312C2 (en
SE8702907D0 (en
Inventor
M Machida
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of SE8702907D0 publication Critical patent/SE8702907D0/en
Publication of SE8702907L publication Critical patent/SE8702907L/en
Publication of SE503312C2 publication Critical patent/SE503312C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Abstract

A stable granulocyte colony stimulating factor containing pharmaceutical preparation is dsiclosed. It contains, in addition to the granulocyte colony stimulating factor present as the effective ingredient, at least one substance selected from the group consisting of a pharmaceutically acceptable surfactant, saccharide, protein and high-molecular weight compound.
SE8702907A 1986-07-18 1987-07-17 Pharmaceutical preparation containing a granulocyte colony-stimulating factor G-CSF SE503312C2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP16948786 1986-07-18
JP16948886 1986-07-18
JP16948686 1986-07-18
JP16948986 1986-07-18

Publications (3)

Publication Number Publication Date
SE8702907D0 SE8702907D0 (en) 1987-07-17
SE8702907L true SE8702907L (en) 1988-01-19
SE503312C2 SE503312C2 (en) 1996-05-13

Family

ID=27474266

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702907A SE503312C2 (en) 1986-07-18 1987-07-17 Pharmaceutical preparation containing a granulocyte colony-stimulating factor G-CSF

Country Status (24)

Country Link
KR (1) KR930004597B1 (en)
CN (1) CN1033738C (en)
AT (1) AT402259B (en)
AU (1) AU611856B2 (en)
BE (1) BE1000253A3 (en)
CA (1) CA1297007C (en)
CH (1) CH671157A5 (en)
DE (1) DE3723781C2 (en)
DK (1) DK171308B1 (en)
ES (1) ES2010226A6 (en)
FR (1) FR2601591B1 (en)
GB (1) GB2193631B (en)
GR (1) GR871067B (en)
HK (1) HK64893A (en)
HU (1) HU198627B (en)
IE (1) IE60290B1 (en)
IL (1) IL83220A (en)
IT (1) IT1218927B (en)
NL (1) NL192917C (en)
NO (1) NO171828C (en)
PT (1) PT85343B (en)
SE (1) SE503312C2 (en)
SG (1) SG64393G (en)
YU (1) YU47543B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
US5981485A (en) 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
GB8824591D0 (en) * 1988-10-20 1988-11-23 Royal Free Hosp School Med Fractionation process
US5349052A (en) * 1988-10-20 1994-09-20 Royal Free Hospital School Of Medicine Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
US6132763A (en) * 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5104651A (en) * 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
JP3249147B2 (en) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド Oral preparation containing bioactive protein
EP0459516A1 (en) * 1990-06-01 1991-12-04 Kirin-Amgen, Inc. Oral dosage form of biologically active proteins
FR2686900B1 (en) * 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa NOVEL POLYPEPTIDES HAVING GRANULOCYTE COLONY STIMULATION ACTIVITY, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2686899B1 (en) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2693907B1 (en) * 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa A method of administering granulocyte colony stimulating factor solutions.
EP0582932A1 (en) * 1992-08-11 1994-02-16 F. Hoffmann-La Roche Ag Therapeutic system for the parenteral administration of hematopoietic growth factors
DE4242863A1 (en) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stable lyophilized pharmaceutical preparations of G-CSF
DE4242919A1 (en) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Process for the preparation of storage-stable aqueous pharmaceutical preparations of G-CSF
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
EP0820299B1 (en) * 1995-02-06 2002-04-24 Genetics Institute, Inc. Formulations for il-12
TW434020B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions
TW434021B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6776983B1 (en) * 1998-03-06 2004-08-17 Chugai Seiyaku Kabushiki Kaisha Protein free formulations
US6979442B1 (en) * 1998-08-17 2005-12-27 Pfizer Inc. Stabilized protein compositions
WO2001017542A1 (en) * 1999-09-08 2001-03-15 Chugai Seiyaku Kabushiki Kaisha Protein solution preparation and method of stabilizing the same
AU2001236005A1 (en) * 2000-02-29 2001-09-12 Chugai Seiyaku Kabushiki Kaisha Preparations stabilized over long time
ES2220673T3 (en) 2000-02-29 2004-12-16 Pfizer Products Inc. STIMULATING FACTOR OF STABILIZED GRANULOCIT COLONIES.
CA2747325A1 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
US7998929B2 (en) 2000-09-01 2011-08-16 Chugai Seikyaku Kabushiki Kaisha Solution preparations stabilized over long time
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
EP1463751B1 (en) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Albumin fusion proteins
EP1541585B1 (en) 2002-08-27 2013-01-30 Biokine Therapeutics Ltd. Cxcr4 antagonist and use thereof
JP4607010B2 (en) 2003-02-28 2011-01-05 中外製薬株式会社 Protein-containing stabilized preparation
DE202006020194U1 (en) 2006-03-01 2007-12-06 Bioceuticals Arzneimittel Ag G-CSF liquid formulation
ES2842210T3 (en) 2006-12-21 2021-07-13 Biokine Therapeutics Ltd 4F-benzoyl-TN14003 for mobilization of hematopoietic progenitor cells for transplantation
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
TWI409082B (en) * 2010-01-19 2013-09-21 Hanmi Science Co Ltd Liquid formulation for long-acting g-csf conjugate
EP2399572A1 (en) 2010-06-22 2011-12-28 Sandoz AG Long-term storage of non-glycosylated recombinant human G-CSF
US10682390B2 (en) 2015-07-16 2020-06-16 Biokine Therapeutics Ltd. Compositions and methods for treating cancer
KR102033920B1 (en) 2016-02-23 2019-10-18 바이오라인알엑스 리미티드 How to treat acute myeloid leukemia
WO2018138267A1 (en) 2017-01-27 2018-08-02 Cinfa Biotech S.L. Method for determining the efficacy of a g-csf containing composition
TW202005628A (en) * 2018-05-21 2020-02-01 日商中外製藥股份有限公司 Lyophilized formulation sealed in glass vial

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652636A1 (en) * 1976-11-19 1978-05-24 Hans Uwe Dr Rer Nat Wolf Stabilising protein during separation, purification and storage - by adding amphiphilic cpds., esp. lipid(s), ionic and or nonionic detergents
SE451844B (en) * 1978-03-20 1987-11-02 Morinaga Milk Industry Co Ltd GLYCOPROTEIN, PROCEDURE FOR PREPARING THEREOF AND THERAPEUTIC AGENTS INCLUDING THE GLYCOPROTEIN
DE3380726D1 (en) * 1982-06-24 1989-11-23 Japan Chem Res Long-acting composition
JPS60228422A (en) * 1984-04-26 1985-11-13 Suntory Ltd Stabilized preparation of physiologically active substance
JPS61227526A (en) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd Novel csf and method of collecting same
JPS6191131A (en) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd Method and composition for preventing adsorption of pharmaceutical
JP2512453B2 (en) * 1985-02-05 1996-07-03 シ−タス コ−ポレ−シヨン Purification of natural colony-promoting factor-1
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
JPH0618778B2 (en) * 1985-10-04 1994-03-16 中外製薬株式会社 Leukopenia treatment

Also Published As

Publication number Publication date
NO171828C (en) 1993-05-12
PT85343B (en) 1990-04-30
CA1297007C (en) 1992-03-10
YU47543B (en) 1995-10-03
GR871067B (en) 1987-11-19
NL192917B (en) 1998-01-05
ATA177587A (en) 1996-08-15
IL83220A (en) 1993-01-31
NO872966L (en) 1988-01-19
IL83220A0 (en) 1987-12-31
ES2010226A6 (en) 1989-11-01
HK64893A (en) 1993-07-16
NL192917C (en) 1998-05-07
IE871933L (en) 1988-01-18
AT402259B (en) 1997-03-25
YU134287A (en) 1989-06-30
AU7566587A (en) 1988-01-21
NO171828B (en) 1993-02-01
DE3723781C2 (en) 1999-09-02
GB2193631B (en) 1990-11-21
KR930004597B1 (en) 1993-06-01
GB2193631A (en) 1988-02-17
SE503312C2 (en) 1996-05-13
SE8702907D0 (en) 1987-07-17
IT8767594A0 (en) 1987-07-10
DK368387A (en) 1988-01-19
NO872966D0 (en) 1987-07-16
CH671157A5 (en) 1989-08-15
CN1033738C (en) 1997-01-08
CN87104963A (en) 1988-02-24
NL8701640A (en) 1988-02-16
FR2601591A1 (en) 1988-01-22
FR2601591B1 (en) 1991-04-26
SG64393G (en) 1993-08-06
IE60290B1 (en) 1994-06-29
AU611856B2 (en) 1991-06-27
DK171308B1 (en) 1996-09-02
DK368387D0 (en) 1987-07-15
GB8716904D0 (en) 1987-08-26
HUT44941A (en) 1988-05-30
KR880001297A (en) 1988-04-22
PT85343A (en) 1987-08-01
DE3723781A1 (en) 1988-01-21
IT1218927B (en) 1990-04-24
HU198627B (en) 1989-11-28
BE1000253A3 (en) 1988-09-27

Similar Documents

Publication Publication Date Title
SE8702907L (en) STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTIC COLONIST STIMULATING FACTOR AND A SET OF PRODUCING ITS
SE8406081D0 (en) METHOD AND COMPOSITION FOR THE PREPARATION OF CONTROLLED LONG-ACTING PHARMACEUTICALS FOR ORAL ADMINISTRATION
LU88306I2 (en) Felodipine (Plendil)
LV10954A (en) Derivatives of benzimidazole as a result of their acquisition and their pharmaceutical composition
FI921030A (en) CYCLIC UREA DERIVATIVES, DESSA FOERENINGAR INNEHAOLLANDE CEILING MODEL
FI865233A (en) PYRAZOLINDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING SOM MEDEL MED INSEKTICID OCH AKARICID VERKAN.
SE8303013D0 (en) B-GAMMA DIHYDROPOLYPRENYLAL ALCOHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING A POLYPRENYL SUBSTANCE
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
SE8404065D0 (en) NOVEL BIOLOGICALLY ACTIVE COMPOUNDS
FR2442836A1 (en) 1,2,4,5-TETRA-ALKYL-4-ARYLPIPERIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
SE8704952L (en) PHARMACEUTICAL COMPOSITION
ES2037709T3 (en) HETERO-CYCLE DERIVATIVES OF SIX MEMBERS OF N, N'-DIACILHIDRAZINAS N'-SUBSTITUTED.
OA07539A (en) New derivatives of phenyl aliphatic acids, their preparation, their application as medicaments, and the compositions containing them.
FR2428629A1 (en) NOVEL BIS (ARYLOXYCARBOXYLIC) COMPOUNDS, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS
SE8700555L (en) PURINE DERIVATIVES, THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE
FI803202L (en) PHOSPHONOHYDROXIAETHYCLE FOERFARANDE FOER DESS FRAMSTAELLNING OCH DESS ANVAENDNING SAOSOM CEILING MODEL
ES8102096A1 (en) Derivatives of 3,4,5-trihydroxypiperidine, processes for their preparation, and their use as medicines and in animal food.
DK527186A (en) SOURCE CHODILATING PHARMACEUTICAL PREPARATION
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
BR7905038A (en) INSECTICID COMPOSITIONS, THEIR USE AND PREPARATION OF THE ACTIVE COMPOUND
ATE18761T1 (en) CARBAMOYLOXYBENZHYDROL DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS.
FR2521142B1 (en) NOVEL N-METHANESULFONIC DERIVATIVES OF DEMETHYL-3-O ISTAMYCIN B, THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS CONTAINING THE SAME
SE8704240D0 (en) ANALGESIC PREPARATIONS
MA20974A1 (en) Propargyloxybenzene derivatives, their preparation and fungicidal compositions containing them
JPS52111576A (en) Synthesis of 5,7,8-trimethyl-3,4-dehydrotocotrienol

Legal Events

Date Code Title Description
NUG Patent has lapsed